Page last updated: 2024-12-08

oxypressin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

oxypressin: equipotent analog of oxytocin & vasopressin; RN given for (L)-Phe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID164712
CHEMBL ID3272682
SCHEMBL ID15511438
MeSH IDM0148485

Synonyms (15)

Synonym
(2s)-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-4-me
[phe3]oxytocin
[phe3]ot
gtpl2178
642-35-3
oxypressin
cysteinyl-tyrosyl-phenylalanyl-glutaminyl-asparaginyl-cysteinyl-proly-leucyl-glycinamide
oxytocin, phe(3)-
3-phe-oxytocin
oxytocin, 3-l-phenylalanine-
cys-tyr-phe-gln-asn-cys-pro-leu-glynh2
oxytocin, phenylalanine(3)-
CHEMBL3272682
SCHEMBL15511438
Q27088366

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"Replacement of the aliphatic isoleucine residue in position 3 of oxytocin (the first corner position of the beta-turn in the 20-membered ring of the solution conformation of the hormone) by phenylalanine has been shown to result in analogues with reduced affinity and intrinsic activity when tested by the individual dose-response procedure on the isolated rat uterus."( Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
Botos, CR; Skala, G; Smith, CW; Walter, R, 1977
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1346453Human V2 receptor (Vasopressin and oxytocin receptors)1995The EMBO journal, May-15, Volume: 14, Issue:10
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
AID1346455Rat V1A receptor (Vasopressin and oxytocin receptors)1995The EMBO journal, May-15, Volume: 14, Issue:10
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
AID1346469Human OT receptor (Vasopressin and oxytocin receptors)1996FEBS letters, Nov-18, Volume: 397, Issue:2-3
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.
AID1346469Human OT receptor (Vasopressin and oxytocin receptors)1995The EMBO journal, May-15, Volume: 14, Issue:10
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor.
AID1149961Agonist activity at oxytocin receptor in virgin rat uterine horns assessed as uterotonic activity at relative to synthetic oxytocin1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
AID1149954Agonist activity at oxytocin receptor in virgin rat uterine horns assessed as uterotonic activity at1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's3 (42.86)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.96 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]